Friedreich ataxia is an autosomal-recessive, neurodegenerative disease that primarily affects the nervous system and heart. It was named after Nicolaus Friedreich, a Professor of Medicine in ...

The FDA has issued a CRL to Biohaven regarding the NDA for troriluzole for the treatment of adults with spinocerebellar ataxia.

A recent study of clinical and genetic characteristics in patients with hereditary spastic paraplegia highlights the difficulties of making clinicogenetic correlations in a heterogeneous group of ...

Investigator & Co-Director of the Neurotherapeutics IWI, Lundquist Institute (Formerly "LA BioMed"); Assistant Professor, David Geffen School of Medicine at UCLA Department of Neurology Ataxia ...

When David Lee first stumbled on the street in Hong Kong seven years ago, unable to walk in a straight line, he had no idea it was an early sign of a rare neurological disorder that would change his ...

After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU. Skyclarys ...

A Birmingham woman detailed her experience after suffering a stroke and said she 'hated everything about her life'. Grace Joy-Bowers suffered a stroke in 2022 during a procedure to treat an issue with ...

Lili Vachon said doctors rang her two weeks later to say 'oh by the way, you've had a stroke' A teacher who had a stroke at the age of 26 says hospital doctors were "convinced that it was a migraine" ...

・Biohaven was seeking approval for its drug Vyglxia in the treatment of Spinocerebellar ataxia. ・The company is in the process of formally requesting a meeting as soon as possible to determine the ...

Infectious meningoencephalitis, characterized by inflammation of both the brain and adjacent meninges, is caused by a variety ...